CYP27A1 and osteoporosis: Furthermore, the patients treated suppressed their markers of bone turnover (i.e., P-CTX) to an average value of 101 ng/L, which is just below the reference value and comparable to the values obtained when using zoledronic acid to treat other diseases, such as osteoporosis.